Meeting sign of acting FDA leadership trying to right the ship

Acting FDA Commissioner Kyle Diamantas is continuing to row the agency into calmer waters amid a search for a permanent commissioner and permanent center directors.

The effort to steer the agency back toward a more conventional regulatory approach, and mend ties with patient advocates, was the clear, if unstated, message Diamantas delivered Wednesday during an off-the-record meeting with 15 rare disease organizations...